No Data
No Data
Treace Medical Concepts(TMCI.US) Director Buys US$93,501 in Common Stock
$Treace Medical Concepts(TMCI.US)$ Director MOTT RICHARD W purchased 18,000 shares of common stock on May 24, 2024 at an average price of $5.1945 for a total value of $93,501.Source: Announcement What
Treace to Present at Truist Securities MedTech Conference
PONTE VEDRA, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions
Treace Medical Concepts(TMCI.US) Director Buys US$60,424.98 in Common Stock
$Treace Medical Concepts(TMCI.US)$ Director MOTT RICHARD W purchased 12,100 shares of common stock on May 22, 2024 at an average price of $4.9938 for a total value of $60,424.98.Source: Announcement W
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock's strength on days when prices go u
Treace Medical Concepts(TMCI.US) 10% Shareholder Buys US$556.17K in Common Stock
$Treace Medical Concepts(TMCI.US)$ 10% Shareholder Treace John T. purchased 100K shares of common stock on May 17, 2024 at an average price of $5.5617 for a total value of $556.17K.Source: Announcemen
Unveiling 6 Analyst Insights On Treace Medical Concepts
Analysts' ratings for Treace Medical Concepts (NASDAQ:TMCI) over the last quarter vary from bullish to bearish, as provided by 6 analysts.The following table summarizes their recent ratings, shedding
No Data